(Q53332122)
Statements
[Lys40(Ahx-DTPA-111In)NH2]-Exendin-4 is a highly efficient radiotherapeutic for glucagon-like peptide-1 receptor-targeted therapy for insulinoma. (English)
Martin Behe
Damian Wild
Daniel Storch
Christian Seemayer
Martin Gotthardt
Stefan Kneifel
Michael J Mihatsch
Jean-Claude Reubi
Helmut R Mäcke
Gerhard Christofori
1 June 2007
13
12
3696-3705